{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20251217",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 5",
          "submission_class_code_description": "Type 5 - New Formulation or New Manufacturer",
          "application_docs": [
            {
              "id": "84462",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761433Orig1s000ltr.pdf",
              "date": "20251219",
              "type": "Letter"
            },
            {
              "id": "84785",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761433s000lbl.pdf",
              "date": "20260121",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "BLA761433",
      "sponsor_name": "JANSSEN BIOTECH",
      "openfda": {
        "application_number": [
          "BLA761433"
        ],
        "brand_name": [
          "RYBREVANT FASPRO"
        ],
        "generic_name": [
          "AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT)"
        ],
        "manufacturer_name": [
          "Janssen Biotech, Inc."
        ],
        "product_ndc": [
          "57894-510",
          "57894-514",
          "57894-515",
          "57894-522"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "AMIVANTAMAB",
          "HYALURONIDASE (HUMAN RECOMBINANT)"
        ],
        "rxcui": [
          "2729297",
          "2729304",
          "2729306",
          "2729307",
          "2735796",
          "2735797",
          "2735803",
          "2735804"
        ],
        "spl_id": [
          "e037897a-b42a-413f-8f3f-c0f5ee7b5125"
        ],
        "spl_set_id": [
          "9e58b045-e352-4f62-99bf-77fae1bebc69"
        ],
        "package_ndc": [
          "57894-510-01",
          "57894-514-01",
          "57894-515-01",
          "57894-522-01"
        ],
        "nui": [
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_epc": [
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_cs": [
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "0JSR7Z0NB6",
          "743QUY4VD8"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "RYBREVANT FASPRO",
          "active_ingredients": [
            {
              "name": "AMIVANTAMAB AND HYALURONIDASE-LPUJ",
              "strength": "14ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTION",
          "route": null,
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "RYBREVANT FASPRO",
          "active_ingredients": [
            {
              "name": "AMIVANTAMAB AND HYALURONIDASE-LPUJ",
              "strength": "10ML"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTION",
          "route": null,
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}